For the first time, researchers have found evidence of a biological cause for the impairments caused by the disease ...
Axsome obtains exclusive global rights to balipodect, a potentially first-in-class selective phosphodiesterase 10A inhibitorAcquisition further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results